ESMO 2018


ITM Isotopen Technologien München AG at ESMO 2018

From 19 to 23 October oncologist and industry experts from around the world will meet at ESMO Congress 2018 in Munich, Germany. Held under the tagline “Securing Access to Optimal Cancer Care” this year’s Congress aims at providing a scientific and educational program able to directly impact the daily clinical practice of oncologists.

At the corresponding trade show – an essential component of ESMO Congress – all major pharmaceutical companies active in the field of oncology will be present at Munich Messe, providing medical oncologists with an ideal platform to network with pharmaceutical partners and a dedicated opportunity to gain further insights into tangible advances in the treatment of cancer.

Visit ITM in Hall B1 Booth 163

ITM Isotopen Technologien München AG will, of course, also be taking part in the exhibition at ESMO Conference. We will be showcasing our portfolio of first-in-class medical radionuclides and generator platforms for a new generation of targeted cancer diagnostics and therapies at our booth in Hall B1 Booth 163.

Chat with our team of dedicated specialists and experts in the field of innovative diagnostic and therapeutic radionuclides and radiopharmaceuticals. Learn all about targeted radionuclide therapy and our growing pipeline of targeted treatments in various stages of clinical development, such as our Neuroendocrine Tumor (NET) therapeutic Solucin® (n.c.a.177Lu-Edotreotide), our NET Diagnostic TOCscan® (68Ga-Edotreotide) and many more exciting things to come.

We are looking forward to meeting you! Come visit us at the ITM booth at ESMO Congress 2018 in Hall B1 Booth 163 or directly book an appointment with one of our experts.

Where: Messe Munich, Messegelaende, 81823 Munich, Germany; ITM Booth Hall B1 Booth 163
When: 19 to 23 October 2018